Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes

H Donaldson, M McCalmont, D M Livermore, P J Rooney, G Ong, E McHenry, R Campbell, R McMullan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A new VITEK 2 antibiotic susceptibility testing (AST) card, AST N-054, was introduced for aerobic gram-negative bacilli in 2007 and has been widely adopted for routine use in the UK. We evaluated its performance for detecting extended-spectrum beta-lactamase (ESBL) production in Escherichia coli.
Original languageEnglish
Pages (from-to)1015-7
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume62
Issue number5
DOIs
Publication statusPublished - Nov 2008

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes'. Together they form a unique fingerprint.

Cite this